Disease | polycystic ovary syndrome |
Comorbidity | C0023895|liver disease |
Sentences | 7 |
PubMedID- 25554608 | Non-alcoholic fatty liver disease in women with polycystic ovary syndrome - clinical and metabolic aspects and lipoprotein lipase gene polymorphism. |
PubMedID- 24639812 | Background: polycystic ovary syndrome (pcos) is highly associated with non-alcoholic fatty liver disease (nafld). |
PubMedID- 24246334 | Obstructive sleep apnea predisposes to nonalcoholic fatty liver disease in patients with polycystic ovary syndrome. |
PubMedID- 25136364 | Cannabinoid receptor 1 gene polymorphisms and nonalcoholic fatty liver disease in women with polycystic ovary syndrome and in healthy controls. |
PubMedID- 23980352 | Objective: to observe the therapeutic effect of resolving method of chinese medicine (cm) on the lipid metabolism in polycystic ovary syndrome (pcos) patients accompanied with non-alcoholic fatty liver disease (nafld), to analyze the correlation between pcos and nafld, and to study its mechanisms. |
PubMedID- 26039829 | Prevalence of non-alcoholic fatty liver disease in women with polycystic ovary syndrome and its correlation with metabolic syndrome. |
PubMedID- 25339805 | Review of nonalcoholic fatty liver disease in women with polycystic ovary syndrome. |
Page: 1